InspireMD, Inc.
NSPRNasdaqCIK 1433607HealthcareFiscal year ends Dec 31
Reports and events: 527 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2109:12 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043488 |
| 2026-08-1707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038624 |
| 2026-08-1416:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038438 |
| 2026-07-2917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-035220 |
| 2026-07-2317:00 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-034430 |
| 2026-07-0217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-031945 |
| 2026-06-1108:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028221 |
| 2026-06-0316:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-027045 |
| 2026-05-2216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-025017 |
| 2026-05-0708:53 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-021636 |
| 2026-05-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-021105 |
| 2026-05-0116:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020891 |
| 2026-04-2417:00 ET | SCHEDULE 13D | Ownership report, active investor | 0001493152-26-018952 |
| 2026-04-2016:30 ET | DEF 14A | Proxy statementPeriod 2026-04-20 | 0001493152-26-018103 |
| 2026-04-0316:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-015127 |
| 2026-03-1808:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-010886 |
| 2026-03-1807:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-010791 |
| 2026-03-0417:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-008894 |
| 2025-12-1916:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-028558 |
| 2025-11-1016:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021503 |
| 2025-11-0416:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-020718 |
| 2025-10-2916:30 ET | SCHEDULE 13D | Ownership report, active investor | 0001493152-25-020078 |
| 2025-10-2916:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-25-020079 |
| 2025-09-1708:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-013828 |
| 2025-09-0816:05 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001493152-25-012805 |
| 2025-08-0509:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-022159 |
| 2025-08-0416:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-022040 |
| 2025-07-3108:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021675 |
| 2025-07-0907:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-018302 |
| 2025-06-2416:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016293 |
| 2025-06-1309:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-014986 |
| 2025-06-0316:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-013433 |
| 2025-06-0316:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-013427 |
| 2025-05-0907:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009364 |
| 2025-05-0816:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009250 |
| 2025-04-1516:15 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001641172-25-004800 |
| 2025-03-1207:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009936 |
| 2025-03-1206:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-009909 |
| 2024-12-1207:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-049727 |
| 2024-12-0908:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-049199 |
| 2024-11-2516:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-047617 |
| 2024-11-1209:27 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-24-044599 |
| 2024-11-1209:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044578 |
| 2024-10-1507:10 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-041036 |
| 2024-10-0707:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001493152-24-039640 |
| 2024-10-0116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-039017 |
| 2024-09-1607:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-036293 |
| 2024-08-0608:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030372 |
| 2024-08-0516:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030265 |
| 2024-07-0107:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-025714 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.